Finally Some Good News as the FDA Lifts Hold on Sanofi, Alnylam's Fitusiran Post author:Sam Post published:December 14, 2017 Post category:BioPharma Clinical trial dosing will resume around year-end 2017. Source: BioSpace You Might Also Like STAAR Surgical And Announce Strategic Cooperation Agreement August 14, 2017 What You Need to Know About Fortis Therapeutics January 22, 2018 3 Biotechs Predicted to Grow 415% and More in 2018 May 3, 2017
